How to Know Wegovy Is Working: Signs That Tell You It's Doing Its Job

Does reduced appetite count as proof Wegovy is working?

Yes, and it is often the first signal most people notice, sometimes within 48 hours of the initial 0.25 mg dose. Semaglutide works as a GLP-1 receptor agonist, mimicking a gut hormone that tells the brain the stomach is full and slows the rate at which food leaves it. The result is not a dramatic suppression; for most people it feels more like a quiet shift in appetite rather than nausea forcing them to stop eating.

A common misconception is that if you are not feeling sick, the medicine is not working. In fact, nausea is a side effect, not a mechanism. Many people on Wegovy lose significant weight without ever feeling unwell. The appetite change you are looking for is subtler: finishing a meal and not thinking about the next one, leaving food on the plate without effort, noticing that a meal you once found small is now enough.

The practical guide to taking Wegovy on this site covers how to support that appetite shift with the right foods and meal timing, which makes it easier to spot whether the medicine is doing its part.

One useful exercise in the first two weeks: note your hunger level before and after meals on a simple scale. It is a low-effort way to track biological change before the scales move.

When should weight actually start to drop?

The scales are a lagging indicator, not the first one. Most people do not see measurable weight loss in week one, and that is normal. The body is adjusting to a lower calorie intake; water retention, digestion and hormonal rhythms all affect the number on any given morning.

By weeks four to eight, a clear downward trend usually becomes visible. The STEP 1 trial, published in the New England Journal of Medicine, found an average reduction of around 15% of body weight at 68 weeks among adults taking semaglutide 2.4 mg alongside a reduced-calorie diet and increased physical activity. That figure is an average across thousands of participants; individual results vary considerably, and the dose at which most participants achieved it was the 2.4 mg maintenance dose, reached after a titration period of several months.

For people wondering how quickly Wegovy begins to have an effect, the honest answer is that appetite changes can appear in days, but meaningful weight reduction takes weeks and continues to build as the dose increases. Comparing your progress to an end-of-trial average in week three is not a useful exercise.

Tracking weight once a week, same time, same conditions, gives a more reliable trend than daily readings. A loss of 0.5–1 kg per week across several weeks is a solid signal that things are moving in the right direction.

What if the weight loss has slowed or seems to have stopped?

A plateau is not always a sign that Wegovy has stopped working. The body naturally adapts its metabolic rate as weight falls, and periods of slower loss are part of that process. The question to ask is whether the plateau has lasted more than four to six weeks with no change in weight, appetite, or energy intake, and whether you are still on the same dose you started on rather than a higher maintenance dose.

NICE's guidance on semaglutide, TA875, notes that continuing treatment should be reviewed if weight loss is less than 5% after six months on the maintenance dose. That is a formal clinical checkpoint, not a reason to panic at week eight. If you are still in the titration phase, the relevant question is whether the next dose increase is due.

For a fuller picture of what happens when progress stalls (and the reasons behind it) the page on whether Wegovy stops working over time covers the evidence and practical options. Physical activity matters too; combining Wegovy with exercise has a measurable effect on the rate and sustainability of weight loss.

If you are on the highest licensed dose and weight remains static after several months, discuss it with your prescriber. There are clinical options, and the answer is not simply waiting it out. Worth checking with your clinical team sooner rather than later.

Are there signs other than weight loss that Wegovy is working?

Several, and they matter, particularly for people whose main concern is a weight-related health condition rather than the number on the scales. Blood pressure, fasting blood glucose and lipid levels can all improve before significant weight is lost. If your GP is monitoring these, changes in those markers are meaningful early signals.

Energy levels often improve as appetite normalises and eating patterns become more consistent. Some people report better sleep, particularly those with obesity-related sleep apnoea. These are biological effects of reduced weight and calorie balance, not placebo.

The semaglutide overview on this site explains the full range of physiological changes associated with the medicine, including its licensed cardiovascular indication for eligible adults. If you want to know how to tell if Wegovy is working for you specifically, that page brings together the key markers, from appetite shifts to blood pressure changes, worth monitoring across the first few months. For a detailed clinical breakdown of what Wegovy is approved for and how doses are structured, the NHS semaglutide page is the clearest patient-level reference available.

If you are thinking about starting Wegovy and want a private route that does not involve a referral or a waiting list, starting a free consultation at nume connects you with a GPhC-registered prescriber who reviews your case the same day.